These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 8212111)

  • 1. Transfusion-associated graft-versus-host disease: scratching the surface.
    Shivdasani RA; Anderson KC
    Transfusion; 1993 Sep; 33(9):696-7. PubMed ID: 8212111
    [No Abstract]   [Full Text] [Related]  

  • 2. Transfusion-associated graft-versus-host disease in nonimmunocompromised hosts.
    Vogelsang GB
    Transfusion; 1990 Feb; 30(2):101-3. PubMed ID: 2137651
    [No Abstract]   [Full Text] [Related]  

  • 3. Transfusion-associated graft-versus-host disease in an immunocompetent patient.
    Capon SM; DePond WD; Tyan DB; Pepkowitz SH; Toyoda H; Cinman AC; Azer PC; Goldfinger D
    Ann Intern Med; 1991 Jun; 114(12):1025-6. PubMed ID: 2029098
    [No Abstract]   [Full Text] [Related]  

  • 4. HLA homozygosity and shared HLA haplotypes in the development of transfusion-associated graft-versus-host disease.
    Shivdasani RA; Anderson KC
    Leuk Lymphoma; 1994 Oct; 15(3-4):227-34. PubMed ID: 7866271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transfusion-associated graft-versus-host disease in immunocompetent patients: report of a fatal case associated with transfusion of blood from a second-degree relative, and a survey of predisposing factors.
    Petz LD; Calhoun L; Yam P; Cecka M; Schiller G; Faitlowicz AR; Herron R; Sayah D; Wallace RB; Belldegrun A
    Transfusion; 1993 Sep; 33(9):742-50. PubMed ID: 8105567
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-matched blood products and posttransfusion graft-versus-host disease.
    Charpentier F; Bracq C; Bonin P; Berling P; Duedari N
    Transfusion; 1990; 30(9):850. PubMed ID: 2238036
    [No Abstract]   [Full Text] [Related]  

  • 7. Transfusion-associated graft-versus-host disease and its prevention.
    Williamson LM; Warwick RM
    Blood Rev; 1995 Dec; 9(4):251-61. PubMed ID: 8839400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Graft-versus-host disease in rhabdomyosarcoma following transfusion with nonirradiated blood products.
    Labotka RJ; Radvany R
    Med Pediatr Oncol; 1985; 13(2):101-4. PubMed ID: 3856732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Graft-versus-host disease: a surge of developments.
    Riddell SR; Appelbaum FR
    PLoS Med; 2007 Jul; 4(7):e198. PubMed ID: 17622190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fatal transfusion-associated graft-vs-host disease.
    Otsuka S; Kasuya S; Hirose M
    Aust N Z J Med; 1993 Jun; 23(3):308-9. PubMed ID: 8352710
    [No Abstract]   [Full Text] [Related]  

  • 11. Transfusion associated graft versus host disease in an immunocompetent patient.
    O'Connor NT; Mackintosh P
    J Clin Pathol; 1992 Jul; 45(7):621-2. PubMed ID: 1517464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [HLA and transfusion].
    Wittmann G; Zimmermann R; Eckstein R
    Infusionsther Transfusionsmed; 1994 Jun; 21(3):207-12. PubMed ID: 7919910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transfusion-induced graft-versus-host disease in patients with malignant lymphoma. A case report and review of the literature.
    Spitzer TR; Cahill R; Cottler-Fox M; Treat J; Sacher R; Deeg HJ
    Cancer; 1990 Dec; 66(11):2346-9. PubMed ID: 2245390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular kinetics of posttransfusion graft-versus-host disease after heart operations.
    Mayumi H; Matsui K; Matsuzaki K; Uchida T; Shinozaki K; Tokunaga K
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):179-82. PubMed ID: 8028366
    [No Abstract]   [Full Text] [Related]  

  • 15. Alloantigens stimulating graft-v-host disease.
    Dupont B; Flomenberg N; Yang SY
    Transplant Proc; 1987 Dec; 19(6 Suppl 7):48-51. PubMed ID: 3424441
    [No Abstract]   [Full Text] [Related]  

  • 16. Transfusion-associated graft-versus-host disease: risk due to homozygous HLA haplotypes.
    Wagner FF; Flegel WA
    Transfusion; 1995 Apr; 35(4):284-91. PubMed ID: 7701545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Post-transfusion graft-versus-host disease].
    Takahashi K
    Rinsho Ketsueki; 1992 May; 33(5):582-6. PubMed ID: 1630009
    [No Abstract]   [Full Text] [Related]  

  • 18. Amplified fragment length polymorphism analysis in the evaluation of posttransfusion graft-versus-host disease in a child undergoing extracorporeal membrane oxygenation.
    DePalma L; Bahrami KR; Kapur S; Short BL; Luban NL
    J Thorac Cardiovasc Surg; 1994 Jul; 108(1):182-4. PubMed ID: 7913148
    [No Abstract]   [Full Text] [Related]  

  • 19. The critical role of blood from HLA-homozygous donors in fatal transfusion-associated graft-versus-host disease in immunocompetent patients.
    Otsuka S; Kunieda K; Kitamura F; Misawa K; Sasaoka I; Hirose M; Kasuya S; Saji S; Noma A
    Transfusion; 1991; 31(3):260-4. PubMed ID: 2003327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [HLA typing in a neonate with posttransfusional graft vs host disease (PT-GVHD)].
    Lista GL; Porcelli F; Mercuriali F; Farè M; Taccone F
    Pediatr Med Chir; 1994; 16(3):285-7. PubMed ID: 7971455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.